WE
ICCC icon

Wealth Effects’s ImmuCell ICCC Stock Holding History

Wealth Effects’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,917
Closed -$62.6K – 222
2024
Q2 		$62.6K Sell
12,917
-2,500
-16% -$12K 0.02% 203
2024
Q1 		$81.7K Hold
15,417
– – 0.03% 212
2023
Q4 		$78.5K Sell
15,417
-200
-1% -$976 0.03% 219
2023
Q3 		$83.4K Sell
15,617
-500
-3% -$2.54K 0.04% 186
2023
Q2 		$80.6K Buy
16,117
+450
+3% +$2.3K 0.04% 192
2023
Q1 		$80.1K Buy
15,667
+17
+0.1% +$110 0.04% 189
2022
Q4 		$95.5K Hold
15,650
– – 0.05% 182
2022
Q3 		$117K Hold
15,650
– – 0.07% 171
2022
Q2 		$136K Hold
15,650
– – 0.08% 173
2022
Q1 		$151K Sell
15,650
-200
-1% -$1.73K 0.07% 191
2021
Q4 		$127K Buy
+15,850
New +$142K 0.05% 205

Other funds holding ICCC

CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealth Effects's ICCC Position: Q3 2024 in Review

Wealth Effects sold out of ImmuCell (ICCC) in Q3 2024, closing a stake of 12,917 shares — an estimated $62.6K sold.

Wealth Effects first reported a position in ICCC in Q4 2021 and held it in 11 quarters. The position peaked at $151K in Q1 2022. 22 funds tracked by Wall St. Rank hold ICCC as of Q3 2024.

  • Wealth Effects reported no remaining ImmuCell position as of Q3 2024 after selling out during the quarter.
  • Wealth Effects sold 12,917 ImmuCell shares in Q3 2024, an estimated $62.6K.
  • Wealth Effects first reported a position in ImmuCell in Q4 2021 and held it in 11 quarters.
  • Wealth Effects's ImmuCell position peaked at $151K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held ImmuCell as of Q3 2024.

Based on Wealth Effects's 13F filing for Q3 2024, filed 21 Oct 2024.